A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2002
11/28/2002	US20020176849 Endomural therapy
11/28/2002	CA2448668A1 Modulation of cd200 receptors
11/28/2002	CA2448120A1 Muscle-specific expression vectors
11/28/2002	CA2447744A1 Method and apparatus for reducing pathogens in a biological sample
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/28/2002	CA2441840A1 Human secreted proteins
11/27/2002	EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002	EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002	EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002	EP1259605A2 Mutated cyclin g1 protein
11/27/2002	EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002	EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002	EP1259592A1 Monocyte-derived dendritic cell subsets
11/27/2002	EP1259591A2 Polypetptides and methods for thymic vaccination
11/27/2002	EP1259269A1 Agent for the treatment of wounds
11/27/2002	EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002	EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002	EP1259245A2 Novel compositions and uses of dictyostatin compounds
11/27/2002	EP1259120A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
11/27/2002	EP1259112A1 Nutritional intervention composition for enhancing and extending satiety
11/27/2002	EP0804210B1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/27/2002	EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002	EP0630409B1 Defective packaging non-oncoviral vectors based on mpmv
11/27/2002	CN1382218A 溶瘤腺病毒 Oncolytic adenovirus
11/27/2002	CN1382158A Multiple cytokine-antibody complexes
11/27/2002	CN1382056A Lactic acid bacteria for treatment and/or prophylaxis of glardiasis
11/27/2002	CN1382043A Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials
11/27/2002	CN1381267A Wound spray for treating burn
11/27/2002	CN1381265A Medicine for treating cholecystitis and its preparing process
11/27/2002	CN1381263A Weight-lossing hypolipemic medicine
11/27/2002	CN1381257A Chinese-medicinal antihypertensive pillow
11/27/2002	CN1381255A Compoiste bear gall spray for treating rhinocleisis and its preparing process
11/27/2002	CN1381252A Chines medicine for treating silicosis
11/27/2002	CN1381241A Process for preparing nano seal bone powder
11/27/2002	CN1381240A Process for preparing conjugated oestrogens from urine of pregnant mare
11/27/2002	CN1381239A Method for extracting composition from cultured leukocyte
11/27/2002	CN1094972C Lactobacillus strains of human origin, their compositions and uses thereof
11/27/2002	CN1094764C Traditional Chinese medicinal powder for treating pharyngolaryngeeal disease
11/27/2002	CN1094763C Traditional Chinese medicinal pill for treating fatigue and tonifying kidney and brain
11/27/2002	CN1094759C Devitalization method for bone-matrix gelatin carrier
11/26/2002	US6486135 Nucleic acid respiratory syncytial virus vaccines
11/26/2002	US6486132 Immunomodulator, immunomodulator food and immunomodulator feed
11/26/2002	US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002	US6485976 Use of adeno-associated virus (AAV) to deliver genes
11/26/2002	US6485968 Ectoparasite saliva proteins and apparatus to collect such proteins
11/26/2002	US6485958 Method for producing recombinant adenovirus
11/26/2002	US6485904 DNA encoding a plasminogen activating protein
11/26/2002	US6485752 Rose hip extract and fish oil for the treatment of pain and stiffness in the joints, such as associated with osteoarthritis
11/26/2002	US6485733 Absorbent article composition for sequestering skin irritants
11/26/2002	US6485723 Enhanced submucosal tissue graft constructs
11/26/2002	US6485722 Method for selective engraftment of drug-resistant hematopoietic stem cells
11/26/2002	US6485721 Treating diabetes, comprising transplanting artificial skin of biopolymer and skin fibroblasts and/or epidermal cells transformed with a recombinant expression vector expressing human proinsulin and/or insulin
11/26/2002	US6485720 Transgene expression systems
11/26/2002	CA2100864C Method for delivering direct feed microorganisms to poultry in ovo
11/26/2002	CA2051289C Viral mediated destruction of neoplastic cells
11/26/2002	CA1341401C Immunosuppressant factor derived from human glioblastoma cells
11/21/2002	WO2002092832A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
11/21/2002	WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002	WO2002092826A2 Composition and method for treating cancer using herpes virus
11/21/2002	WO2002092825A2 Retroviral vectors for gene therapy
11/21/2002	WO2002092816A1 Replication vector showing cell-specific expression
11/21/2002	WO2002092796A1 Papilloma pseud-virus and it's preparation
11/21/2002	WO2002092793A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes
11/21/2002	WO2002092792A2 Antigen-dependent reduction of specific immune responses by influencing co-stimulation
11/21/2002	WO2002092791A1 Tissues or organs for use in xenotransplantation
11/21/2002	WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002	WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002	WO2002092756A2 Insulin producing cells derived from human embryonic stem cells
11/21/2002	WO2002092540A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002	WO2002092139A1 Methods for inactivating viruses
11/21/2002	WO2002092125A1 Compositions for use in treating ige-associated disorders
11/21/2002	WO2002092122A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	WO2002092114A1 Preventives and/or remedies for fish infections
11/21/2002	WO2002092111A1 Use of extracts and preparations from iris plants and tectorigenin as medicaments
11/21/2002	WO2002092066A1 Antitumor preparation devoid of side effect
11/21/2002	WO2002092054A2 Immune modulation device for use in animals
11/21/2002	WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002	WO2002091999A2 Treatment for wounds
11/21/2002	WO2002091997A2 Oncolytic virus therapy
11/21/2002	WO2002091996A2 Methods for treating cancer
11/21/2002	WO2002091857A1 Health food and method for preparation thereof
11/21/2002	WO2002091833A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
11/21/2002	WO2002078449A3 Method for facilitating the production of differentiated cell types and tissues from embryonic and adult pluripotent and multipotent cells
11/21/2002	WO2002072798A9 Fas ligand-expressing hematopoietic cells for transplantation
11/21/2002	WO2002066068A3 Method of treating neurological diseases
11/21/2002	WO2002063938A9 Production and use of dopaminergic cells to treat dopaminergic deficiencies
11/21/2002	WO2002051264A3 Nutritional composition with health promoting action containing oligo-saccharides
11/21/2002	WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002	WO2001087350A3 Treatment of human papillomavirus (hpv)-infected cells
11/21/2002	WO2001025465A9 Adeno-associated viruses and uses thereof
11/21/2002	WO2001025462A9 Production of recombinant aav using adenovirus comprising aav rep/cap genes
11/21/2002	US20020173806 Method for autologous transplantation
11/21/2002	US20020173642 Human gastric cancer antigen gene and gastric cancer antigen protein
11/21/2002	US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020172958 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
11/21/2002	US20020172705 Bioengineered tissue constructs and methods for producing and using thereof
11/21/2002	US20020172690 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/21/2002	US20020172666 Mixing a platelet concentrate with calcium chloride and batroxobin, wherein platelet concentrate is obtained by centrifuging venous blood; centrifuging the recovered platelet rich plasma; suspending pellets in platelet poor plasma

1 ... 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 ... 1259